Merck Beats Quarterly Estimates, Lifts Outlook on Sales of Cancer Drug, HPV Shot Investing News admin August 1, 2023 0 58 1 minute read Merck reported better-than-expected results and raised its sales outlook on rising drug and vaccine sales.